|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
28 January 2013 |
|
Main ID: |
NCT00214123 |
|
Date of registration:
|
13/09/2005 |
|
Primary sponsor: |
|
|
Public title:
|
Hypofractionated Radiotherapy for Lung Cancer
|
|
Scientific title:
|
The Use of Helical Tomotherapy to Achieve Dose-per-fraction Escalation in Lung Cancer |
|
Date of first enrolment:
|
June 2004 |
|
Target sample size:
|
60 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00214123 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Anne Traynor, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Wisconsin, Madison |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Thoracic neoplasm requiring at lest 60 Gy conventional radiotherapy
Exclusion Criteria:
- Prior bleomycin or gemcitabine chemotherapy
- Prior thoracic radiotherapy
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Lung Cancer
|
|
Intervention(s)
|
|
Radiation: radiation therapy (radiotherapy)
|
|
Primary Outcome(s)
|
|
Grade 3 pneumonitis lasting greater than 2 weeks
[Time Frame: 90 days post radiotherapy (XRT)]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|